AMP Releases Statement on Diagnostics in Drug Labels
Monday, May 16, 2011 - 09:30
in Health & Medicine
Today, at a meeting with the Food and Drug Administration, the Association for Molecular Pathology (AMP) released its new position statement on reference to diagnostic tests in drug labels. AMP's statement outlines the organization's commitment to providing high quality medical care and ensuring patients have access to the most appropriate diagnostic tests based on their clinical presentation.